240 related articles for article (PubMed ID: 35928606)
21. CHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillation.
Xing Y; Ma Q; Ma X; Wang C; Zhang D; Sun Y
Clin Interv Aging; 2016; 11():941-6. PubMed ID: 27478371
[TBL] [Abstract][Full Text] [Related]
22. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
[TBL] [Abstract][Full Text] [Related]
23. CHA
Modi R; Patted SV; Halkati PC; Porwal S; Ambar S; Mr P; Metgudmath V; Sattur A
Int J Cardiol; 2017 Feb; 228():1002-1006. PubMed ID: 27915215
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of CHA
Liu J; Ma Y; Bu H; Qin W; Shi F; Zhang Y
Clin Appl Thromb Hemost; 2022; 28():10760296211073969. PubMed ID: 35060399
[TBL] [Abstract][Full Text] [Related]
25. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.
Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH
Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528
[TBL] [Abstract][Full Text] [Related]
26. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.
Mitchell LB; Southern DA; Galbraith D; Ghali WA; Knudtson M; Wilton SB;
Heart; 2014 Oct; 100(19):1524-30. PubMed ID: 24860007
[TBL] [Abstract][Full Text] [Related]
27. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.
Cetin M; Cakici M; Zencir C; Tasolar H; Baysal E; Balli M; Akturk E
Am J Cardiol; 2014 Mar; 113(6):950-6. PubMed ID: 24444782
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery disease severity and risk stratification of patients with non ST-elevation acute coronary syndrome using CHA
Abdelmegid MAF; Hanna MEF; Demitry SR; Abdelhafez MAH
BMC Cardiovasc Disord; 2024 May; 24(1):263. PubMed ID: 38773382
[TBL] [Abstract][Full Text] [Related]
29. Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Fang C; Chen Z; Zhang J; Jin X; Yang M
Int J Clin Pract; 2022; 2022():3659381. PubMed ID: 36225534
[TBL] [Abstract][Full Text] [Related]
30. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
Chan YH; Yiu KH; Lau KK; Yiu YF; Li SW; Lam TH; Lau CP; Siu CW; Tse HF
Atherosclerosis; 2014 Dec; 237(2):504-13. PubMed ID: 25463082
[TBL] [Abstract][Full Text] [Related]
31. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
[TBL] [Abstract][Full Text] [Related]
32. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
[TBL] [Abstract][Full Text] [Related]
33. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
34. CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention.
Cicek G; Yıldırım E
Kardiol Pol; 2018; 76(1):91-98. PubMed ID: 28980300
[TBL] [Abstract][Full Text] [Related]
35. Novel composite scoring system to predict unknown atrial fibrillation in acute ischemic stroke patients.
Liu R; Yang X; Li S; Jiang Y; Wang Y; Wang Y
Brain Res; 2017 Nov; 1674():36-41. PubMed ID: 28823956
[TBL] [Abstract][Full Text] [Related]
36. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
37. Comparison of CHA
Hu WS; Lin CL
Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
[TBL] [Abstract][Full Text] [Related]
38. CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are associated with 3-month functional outcome of stroke in patients with prior coronary artery disease.
Hoshino T; Ishizuka K; Shimizu S; Uchiyama S
Circ J; 2014; 78(6):1481-5. PubMed ID: 24694770
[TBL] [Abstract][Full Text] [Related]
39. Association of CHA2DS2-VASc score with successful recanalization in acute ischemic stroke patients undergoing endovascular thrombectomy.
Nasifov M; Ozmen E; Deniz C; Nadir A; Ozden O; Bingol G; Jafarov P; Asil T; Goktekin O; Sari I
Postepy Kardiol Interwencyjnej; 2022 Sep; 18(3):269-275. PubMed ID: 36751289
[TBL] [Abstract][Full Text] [Related]
40. CHA
Bozbay M; Uyarel H; Cicek G; Oz A; Keskin M; Murat A; Yildirim E; Karaca G; Ergelen M; Eren M
Clin Appl Thromb Hemost; 2017 Mar; 23(2):132-138. PubMed ID: 27170782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
